MD vs NHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

MD

55.5
AI Score
VS
MD Wins

NHC

37.6
AI Score

Investment Advisor Scores

MD

56score
Recommendation
HOLD

NHC

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MD NHC Winner
Forward P/E 8.2102 9.8912 MD
PEG Ratio 0.2433 0.8241 MD
Revenue Growth 4.0% 8.8% NHC
Earnings Growth 6.5% 67.1% NHC
Tradestie Score 55.5/100 37.6/100 MD
Profit Margin 9.0% 9.0% NHC
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL MD

Relative Price Performance (Last 90 Days)

MD 1M: +3.9% · 3M: +23.3% NHC 1M: +5.4% · 3M: +19.1%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.6% over 20 days), RSI 54

RSI (14): 53.9 · Price: $26.57

NHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.7% over 20 days), RSI 60

RSI (14): 59.8 · Price: $233.40

Fundamentals Snapshot

Metric MD NHC
Market Cap
Forward P/E 10.9 9.9
Trailing P/E 12.5 26.3
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.4%
Operating Margin 0.1% 0.1%
EPS 2.09 9.00
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.